1511 tracked 13F filers disclose a position in CME as of the latest SEC 13F filings, a combined $81.3B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $9.3B | 31.4M | ▲+1.2% Added · +370K sh | Q1 2026 | |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $6.9B | 23.4M | →First observed position No prior filed position | Q1 2026 | |
| 3 | STATE STREET CORP | $3.6B | 16.3M | ▲+1.8% Added · +291K sh | Q2 2026 | |
| 4 | JPMORGAN CHASE & CO | $3.6B | 12.2M | ▲+10.0% Added · +1.1M sh | Q1 2026 | |
| 5 | MORGAN STANLEY | $2.8B | 9.4M | ▲+12% Added · +1.0M sh | Q1 2026 | |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | $2.0B | 9.3M | ▲+1.4% Added · +124K sh | Q2 2026 | |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.7B | 9.0M | →First observed position No prior filed position | Q1 2026 | |
| 8 | NORGES BANK | $1.5B | 5.6M | ▼−2.2% Reduced · −123K sh | Q4 2025 | |
| 9 | Bank of New York Mellon Corp | $1.4B | 4.8M | ▼−1.9% Reduced · −92K sh | Q1 2026 | |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | $1.4B | 4.8M | ▼−30% Reduced · −2.1M sh | Q1 2026 | |
| 11 | RAYMOND JAMES FINANCIAL INC | $1.3B | 4.4M | ▲+1.3% Added · +55K sh | Q1 2026 | |
| 12 | Sanders Capital, LLC | $1.2B | 4.2M | ▼−0.4% Reduced · −16K sh | Q1 2026 | |
| 13 | BANK OF AMERICA CORP /DE/ | $1.2B | 4.0M | ▲+39% Added · +1.1M sh | Q1 2026 | |
| 14 | FMR LLC | $1.1B | 3.8M | ▼−6.4% Reduced · −256K sh | Q1 2026 | |
| 15 | AMERIPRISE FINANCIAL INC | $1.1B | 3.7M | ▲+0.5% Added · +19K sh | Q1 2026 | |
| 16 | FRANKLIN RESOURCES INC | $1.1B | 3.7M | ▲+7.9% Added · +270K sh | Q1 2026 | |
| 17 | GOLDMAN SACHS GROUP INC | $1.1B | 3.6M | ▲+11% Added · +341K sh | Q1 2026 | |
| 18 | NORTHERN TRUST CORP | $1.0B | 3.6M | ▼−0.8% Reduced · −28K sh | Q1 2026 | |
| 19 | Alphabet Inc. | $769.4M | 3.5M | —Held | Q2 2026 | |
| 20 | FIL Ltd | $1.0B | 3.4M | ▼−5.1% Reduced · −183K sh | Q1 2026 | |
| 21 | Capital Wealth Planning, LLC | $711.7M | 3.2M | ▲+41% Added · +934K sh | Q2 2026 | |
| 22 | ROYAL BANK OF CANADA | $871.3M | 3.0M | ▼−10% Reduced · −329K sh | Q1 2026 | |
| 23 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $826.5M | 2.8M | ▲+8.5% Added · +220K sh | Q1 2026 | |
| 24 | Mitsubishi UFJ Asset Management Co., Ltd. | $821.6M | 2.8M | ▲+1.5% Added · +40K sh | Q1 2026 | |
| 25 | PineStone Asset Management Inc. | $600.5M | 2.7M | ▲+4.8% Added · +125K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 1 fund opened a new position in CME and 20 added to an existing one, while 29 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 973 funds | $385.1B |
| AMAZON.COM INCAMZN | 954 funds | $294.3B |
| NVIDIA CORPNVDA | 947 funds | $536.4B |
| ALPHABET INC-CL AGOOGL | 944 funds | $258.0B |
| APPLE INCAAPL | 941 funds | $416.0B |
| JPMORGAN CHASE & COJPM | 919 funds | $102.2B |
| META PLATFORMS INC-CLASS AMETA | 917 funds | $162.3B |
| VISA INC-CLASS A SHARESV | 912 funds | $95.9B |
| BROADCOM INCAVGO | 911 funds | $208.9B |
| ALPHABET INC-CL CGOOG | 900 funds | $177.9B |
| ELI LILLY & COLLY | 900 funds | $113.4B |
| JOHNSON & JOHNSONJNJ | 886 funds | $71.1B |
Ranked by how many of CME's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | SHEPARD WILLIAM R | Director | Buy (P) | 14 | $3K |
| Jun 25, 2026 | SHEPARD WILLIAM R | Director | Buy (P) | 325 | $75K |
| May 18, 2026 | Piell Hilda Harris | Sr MD & Chief HR Officer | Sell (S) | 6K | $1.8M |
| May 15, 2026 | DUFFY TERRENCE A | Chairman and CEO, Director | Sell (S) | 26K | $7.8M |
| May 15, 2026 | DUFFY TERRENCE A | Chairman and CEO, Director | Sell (S) | 9K | $2.7M |
| Mar 26, 2026 | SHEPARD WILLIAM R | Director | Buy (P) | 1K | $419K |
| Mar 26, 2026 | SHEPARD WILLIAM R | Director | Buy (P) | 62 | $18K |
| Mar 17, 2026 | Marcus Jonathan L | Sr MD General Counsel | Sell (S) | 3K | $1.0M |
| Mar 12, 2026 | Vroman Ken | Chief Transformation Officer | Sell (S) | 5K | $1.6M |
| Mar 6, 2026 | Cook Elizabeth A | Director | Sell (S) | 1K | $320K |
| Feb 23, 2026 | Durkin Bryan T | Director | Sell (S) | 4K | $1.3M |
| Feb 20, 2026 | GEPSMAN MARTIN J | Director | Sell (S) | 300 | $92K |
Connected entities for CME
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/CME/capital-change-brief"
Use Arkolith's capital_change_brief for CME. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CME. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.